CHINA ENERGY and the offeror, Alpha Eagle Limited, jointly issued an announcement, declaring the dispatch of the comprehensive document related to the tender offer on January 13. On this occasion, Alpha Eagle Limited launched a mandatory unconditional cash offer through Cinda International Capital Limited to acquire all the issued shares and outstanding convertible bonds of CHINA ENERGY.
Biocytogen (2315) announced on January 12 an option and license agreement with Acepodia, granting global exclusive options on two BsADC projects to accelerate bispecific antibody-dual drug conjugate (BsAD2C) development. Biocytogen will receive upfront and subsequent milestone payments plus royalties. The collaboration combines Biocytogen's RenLite® platform with Acepodia's AD2C technology, building upon a joint development partnership initiated earlier this year. Acepodia and its ultimate beneficial owners are independent of Biocytogen and its connected persons, and the transaction does not constitute a connected transaction. The company cautions shareholders and potential investors to exercise prudence when trading its shares.
FEG Holdings (1413) announced on January 12 that it signed a non-binding strategic cooperation framework agreement with Sichuan Kuaike Automotive Service Co., Ltd. on December 30, 2025, to jointly develop the online ride-hailing and new energy mobility market in Greater China. Cooperation areas include market expansion, new energy vehicle operations, and charging/swapping network construction. The core management team comprises Sun Shifeng, Zhu Xunqing, Ji Xiaofeng, and Meng Junjun. The Board views the partnership as aligning with its growth strategy but emphasized that the agreement is only preliminary, with no binding terms for specific projects, uncertain prospects for advancement, and does not constitute a notifiable transaction under listing rules.
Softcare (2698) announced on January 12 that, due to changes in key personnel at Dongwu Securities International Financing Limited, both parties have agreed to terminate the compliance adviser agreement effective January 12, 2026, and concurrently appointed China Ping An Capital (Hong Kong) Limited, where the former Dongwu personnel now work, as the new compliance adviser. The appointment runs until either the compliance date for 2026 financial results or termination under the agreement, whichever is earlier. Both the Board and Dongwu Securities confirmed no other matters require shareholders' or the Stock Exchange's attention.
Dongfeng Motor Group's 2025 full-year sales reached 1.896 million units, up 0.01% YoY, with new energy vehicle sales of 563,000 units (+42.6% YoY) emerging as the key growth driver. Voyah sales grew 87.4% and M-Hero jumped nearly five-fold, while the three major joint venture brands—Dongfeng Nissan, Dongfeng Honda, and DPCA—all posted declines. Heavy-duty truck segment performed strongly, rising 25.3% YoY to 181,000 units. The company cautioned that data remains unaudited and unconfirmed by auditors.
SHENZHENEXPRESS and its controlling shareholder SHENZHEN INT'L jointly announced that they have subscribed to structured deposits from Bank of Jiangsu in two installments on January 9 and 12. Each installment has a principal of RMB500 million, totaling RMB1 billion. Both products are principal-guaranteed floating-income type with a term of 66 days and a yield rate range of 1.2%-3.3%.
WuXi AppTec (02359.HK) has issued a positive profit warning, projecting that its net profit attributable to shareholders for the 2025 fiscal year will surge by approximately 102.65% year-on-year to around RMB 19.15 billion. This growth is mainly driven by the steady expansion of its core CRDMO business and non-recurring investment gains. Meanwhile, the company’s operating revenue is expected to climb by about 15.84% year-on-year to roughly RMB 45.46 billion.
CYBERNAUT INT’L announced that to align with the company's development needs and enhance corporate governance standards, Executive Director Kong Junmin has been appointed as Chief Executive Officer (CEO), effective January 12, 2026.
SAMPLE TECH announced that it has confirmed Nanjing Institute of Metrology Supervision and Inspection as the transferee of the assets through a public listing process. A transaction agreement was signed on January 8, 2026, specifying the transfer of relevant assets at a consideration of RMB187 million (including value-added tax). The transaction has obtained shareholder and regulatory approvals and is expected to be completed by the end of the first half of 2026.
XIAOMI-W(01810.HK) will spend HKD 151.33 million to repurchase 4 million shares on Jan 9, 2026 .
GIANT BIOGENE(02367.HK) will spend HKD 13.76 million to repurchase 400 thousand shares on Jan 9, 2026 .
DMALL(02586.HK) will spend HKD 5.52 million to repurchase 703 thousand shares on Jan 9, 2026 .
GEELY AUTO(00175.HK) will spend HKD 26.62 million to repurchase 1.55 million shares on Jan 9, 2026 .
TENCENT(00700.HK) will spend HKD 635.93 million to repurchase 1.04 million shares on Jan 9, 2026 .
SUNNY OPTICAL(02382.HK) will spend HKD 53.99 million to repurchase 840 thousand shares on Jan 9, 2026 .
STANCHART(02888.HK) will spend GBP 9.97 million to repurchase 552.73 thousand shares on Jan 8, 2026 .
